Karen Y Repine

US Patent:

55960111, Jan 21, 1997

Filed:

Apr 6, 1995

Appl. No.:

8/418645

Inventors:

Karen M. Repine - Englewood CO
John E. Repine - Englewood CO

International Classification:

A61K 31425
A61K 31195
A61K 3113

US Classification:

514369

Abstract:

Macular degeneration is an age-related eye disease for which there is no known treatment to date that has been shown to be effective at treating or preventing the onset or progression of the disease. Current treatment of non-exudative (dry form) macular degeneration is limited to early diagnosis and careful followup, while symptomatic treatment of exudative (wet form) macular degeneration includes laser photocoagulation therapy, surgery, low dose radiation (teletherapy), and anti-oxidant or anti-inflammatory therapies. The present invention relates to a new method for treating or preventing the onset or progression of macular degeneration, comprising periodic administration of a glutathione (GSH) enhancing agent alone or in conjunction with at least one of an anti-oxidant or an anti-inflammatory therapy, and possibly in addition to one or more of the symptomatic treatments mentioned above.